Esketamine, also known as-ketamine or S-ketamine, is the S enantiomer of ketamine, is a dissociative hallucinogen medication used as a general anesthetic and as an antidepressant for treatment of depression.
What is it?
SPRAVATO® is a prescription medicine, used along with an antidepressant taken by mouth to treat:
- Adults with treatment-resistant depression (TRD)
- Depressive symptoms in adults with major depressive disorder (MDD) with suicidal thoughts or actions
SPRAVATO® (esketamine) CIII nasal spray is the S-enantiomer of racemic ketamine. SPRAVATO® is an FDA-approved nasal spray for TRD and MDSI. Ketamine infusion has not been approved by the FDA to treat depression. There are no head-to-head studies comparing esketamine and ketamine infusion. Both SPRAVATO® and ketamine are Schedule III controlled substances under the U.S. Controlled Substances Act.
SPRAVATO® should be administered in conjunction with an oral antidepressant (AD).
The cost of SPRAVATO® depends on your insurance plan.
No, SPRAVATO® must be administered in a certified healthcare setting.
Get Started with Spravato®
If you’re interested in Spravato® or wondering if it may be right for you, please contact us! We’re ready to help you get started.